Mesoblast Limited American Depositary Shares

Go to Mesoblast Limited American Depositary Shares Website

$15.43

0.00 (0.00%)
Live
Previous Close

$15.43

Day Range

$0 - $0

Previous Day Range

$15.16 - $15.4862

Market Cap

$1.9 billion USD

Day Vol.

0

Previous Day Vol.

56817

Currency

USD

Primary Exchange

Nasdaq

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a cent...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Mesoblast reported $13.2 million in gross revenue from Ryoncil® sales in its first quarter post-launch, with expanding insurance coverage and ongoing efforts to onboard major U.S. transplant centers for treating pediatric steroid-refractory acute graft-versus-host disease.

Related tickers: MESO.

Read Full Article

Mesoblast provided updates on its interactions with the FDA regarding the accelerated approval pathway for Revascor in ischemic heart failure and the label extension for Ryoncil in adults with graft-versus-host disease. The company also reported on the strong commercial launch of Ryoncil in the US.

Related tickers: MESO.

Read Full Article
Trending Tickers

Please sign in to view